Most Android projects don’t fail because of bad developers. They fail because of bad technology decisions. If your mobile app development is taking too long,...Read More The post Kotlin vs Java in ...

The current OpenJDK 26 is strategically important and not only brings exciting innovations but also eliminates legacy issues like the outdated Applet API.

The most widely adopted computer language in history, COBOL is now causing a host of problems. It's also dangerously difficult to remove.

Overview: Programming languages are the foundation of modern technologies, including artificial intelligence, cloud computing, and software development.Language ...

Overview: Learning one programming language and core concepts builds the base for solving coding interview problems effectively.Strong knowledge of data structu ...

This call for proposals (CFP) invites eligible nonprofit organizations in the U.S. to apply for a grant to collect, analyze, and use data to address inequities in the physical, economic, and social ...

Starlink says it may also share personal data with partners to help it "develop AI-enabled tools that improve your customer experience.” Joe Supan is a senior writer for CNET covering home technology, ...

Federal immigration agents detain a man during an operation by Immigration and Customs Enforcement (ICE) and Border Patrol in St. Paul, Minnesota, on Jan. 27, 2026. (Photo by Octavio JONES / AFP via ...

The Education Department sent a message to colleges and universities nationwide Thursday: Any that use data released this year by a massive student voting study risk being labeled violators of a ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Java ranked third in the Tiobe Index for January 2026 at 8.71%, holding steady behind Python and C and just ahead of C++. Tiobe named C# its Programming Language of the Year for 2025 after the largest ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...